19 Dec 2022 11:15
SkinBioTherapeutics PLC SkinBioTherapeutics will 'continue to be flexible enough to adapt to opportunities' 19.12.2022 / 12:14 CET/CEST The issuer is solely responsible for the content of this announcement. Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com News Source: News Direct19.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com |
| Language: | English |
| Company: | SkinBioTherapeutics PLC |
| United States | |
| ISIN: | GB00BF33H870 |
| EQS News ID: | 1516547 |
| End of News | EQS News Service |
1516547 19.12.2022 CET/CEST
corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.
Skinbiotherap. (SBTX)